Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Molecular Profile | NTRK2 loss |
| Therapy | GNF-4256 |
| Indication/Tumor Type | neuroblastoma |
| Response Type | no benefit |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| NTRK2 loss | neuroblastoma | no benefit | GNF-4256 | Preclinical | Actionable | In a preclinical study, GNF-4256 treatment had no effect on the growth of Ntrk2-null neuroblastoma cell lines in culture (PMID: 25394774). | 25394774 |
| PubMed Id | Reference Title | Details |
|---|---|---|
| (25394774) | TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts. | Full reference... |